<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Genomic Expression</title>
    <description>RNA Platform for Next Generation Cures. By analyzing RNA we can detect disease, monitor health and design Next Generation Cures. </description>
    <link>https://www.genomicexpression.com/</link>
    <atom:link href="https://www.genomicexpression.com/blog/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>Will your cancer treatment be determined by an algorithm/AI?</title>
      <pubDate>Sat, 04 Jan 2025 13:56:33 -0800</pubDate>
      <link>https://www.genomicexpression.com/blog/will-your-cancer-treatment-be-determined-by-an-algorithm-ai</link>
      <guid>https://www.genomicexpression.com/blog/will-your-cancer-treatment-be-determined-by-an-algorithm-ai</guid>
      <description>&lt;p&gt;Algorithms are already used today in the treatment selection of cancer patients; however, they are not very sophisticated and assume that most patients' tumors are identical based on a few biomarkers. When using these algorithms, between 50-80% of patients either don't respond or recur after treatment and for that reason, we need to improve the treatment selection algorithms used in the clinic. &lt;/p&gt;&lt;p&gt;Today, novel algorithms based on genomic information can improve treatment selection for individual patients by simply analyzing a tumor sample using next-generation sequencing. &lt;/p&gt;&lt;p&gt;This is no longer futuristic; it is precisely what Genomic Expression has been developing since 2017, and their algorithms have now been clinically validated in breast and ovarian cancer. Their RNA Platform, called OneRNA®, is ready for launch as a treatment navigation tool. &lt;/p&gt;&lt;p style="font-size: 24px;"&gt;&lt;strong&gt;How RNA algorithms are translated to individualized cancer treatments &lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Algorithms can find what you're looking for on Google or suggest your next movie on Netflix. This is, in principle, not different. AI is supercharging the interpretation of massive amounts of data where the human brain and other tools fail simply because of the complexity. &lt;/p&gt;&lt;p&gt;The company Genomic Expression Inc has developed a method for analyzing samples from tumors, where they quantify all RNA’s inside the cancer tissue and use algorithms to find the best treatment regimen.&lt;/p&gt;&lt;p&gt;Data from sequencing RNA is run through multiple data processes to eliminate all bias, and then the data is compared to normal tissue to identify abnormal genes. An algorithm then lists several approved drugs that interrogate the abnormal genes in the tumor based on a proprietary drug database. &lt;/p&gt;&lt;p&gt;Cancer dramatically changes the RNA expression levels; Genomic Expression has demonstrated that it's possible to treat each cancer patient exceptionally accurately with the right intervention by analyzing how...&lt;a href=https://www.genomicexpression.com/blog/will-your-cancer-treatment-be-determined-by-an-algorithm-ai&gt;Read More&lt;/a&gt;</description>
    </item>
    <item>
      <title>How to save $1 billion on drug development</title>
      <pubDate>Wed, 21 Sep 2022 15:21:24 -0700</pubDate>
      <link>https://www.genomicexpression.com/blog/how-to-save-1-billion-on-drug-development</link>
      <guid>https://www.genomicexpression.com/blog/how-to-save-1-billion-on-drug-development</guid>
      <description>&lt;p class="reader-text-block__paragraph" style="text-align: start; font-size: var(--font-size-large);"&gt;&lt;span style="color: #000000; "&gt;Executing clinical studies during the pandemic has been challenging. However, innovations such as &lt;/span&gt;&lt;span style="color: #000000; "&gt;&lt;u&gt;&lt;strong&gt;telehealth&lt;/strong&gt;&lt;/u&gt;&lt;/span&gt;&lt;span style="color: #000000; "&gt; and &lt;/span&gt;&lt;span style="color: #000000; "&gt;&lt;u&gt;&lt;strong&gt;decentralized clinical studies&lt;/strong&gt;&lt;/u&gt;&lt;/span&gt;&lt;span style="color: #000000; "&gt; with access to &lt;/span&gt;&lt;span style="color: #000000; "&gt;&lt;u&gt;&lt;strong&gt;liquid biopsies that can be collected at home&lt;/strong&gt;&lt;/u&gt;&lt;/span&gt;&lt;span style="color: #000000; "&gt; offer a new paradigm for the future.&lt;/span&gt;&lt;/p&gt;&lt;p class="reader-text-block__paragraph tvm__text--legacy-publishing-emphasis tvm__text--legacy-publishing-emphasis tvm__text--legacy-publishing-emphasis" style="text-align: start; font-size: var(--font-size-large);"&gt;&lt;span style="color: #000000; "&gt;Genomic Expression has developed OneRNA®; a novel RNA Platform for Next-Generation Cures, that we can leverage to inspire, Insilco model, then design, stratify, and ultimately de-risk clinical studies.&lt;/span&gt;&lt;/p&gt;&lt;p class="reader-text-block__paragraph" style="text-align: start; font-size: 24px;"&gt;&lt;span style="color: #000000; "&gt;&lt;strong&gt;Implementing biomarkers can save drug developers + $1 billion&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="reader-text-block__paragraph" style="text-align: start; font-size: var(--font-size-large);"&gt;&lt;span style="color: #000000; "&gt;Clinical drug development is risky and costly; however, using biomarkers that inform response-and-resistance mechanism, patient selection, and minimal residual disease can greatly reduce risk, size, and length of study and, therefore, cost.&lt;/span&gt;&lt;/p&gt;&lt;p class="reader-text-block__paragraph" style="text-align: start; font-size: 24px;"&gt;&lt;span style="color: #000000; "&gt;&lt;strong&gt;Biomarkers are going digital&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="reader-text-block__paragraph" style="text-align: start; font-size:...&lt;a href=https://www.genomicexpression.com/blog/how-to-save-1-billion-on-drug-development&gt;Read More&lt;/a&gt;</description>
    </item>
    <item>
      <title>How RNA changed the future of life science</title>
      <pubDate>Mon, 14 Dec 2020 15:28:45 -0800</pubDate>
      <link>https://www.genomicexpression.com/blog/how-rna-changed-the-future-of-life-science</link>
      <guid>https://www.genomicexpression.com/blog/how-rna-changed-the-future-of-life-science</guid>
      <description>&lt;p&gt;RNA stands for ribonucleic acid, a nucleic acid present in all living cells. Its principal role is to act as a messenger, carrying instructions from DNA for controlling the synthesis of proteins. Although, in some viruses, RNA rather than DNA carries the genetic information. COVID-19 is an example of an RNA virus.&lt;/p&gt;&lt;p&gt;There are more than 20,000 protein coding RNA molecules in humans. The way we have developed drugs in the past has been by producing drugs that interact with the key protein that was altered due to contracting the disease.&lt;/p&gt;&lt;p&gt;A poster child for this concept is Herceptin, which is a manmade antibody that blocks the action of a protein called “human epidermal growth factor” coded for by a gene called ERBB2 or Her2.&lt;/p&gt;&lt;p&gt;A significant number of cancer drugs have been developed using this proven method, however the cancer cells often mutate, rendering the drug ineffective.&lt;/p&gt;&lt;p&gt;Today it is possible to interact with the RNA in cancer and other cells in a number of novel ways, some that make the RNA “drug-able”, and others that make the RNA a drug itself.&lt;/p&gt;&lt;p&gt;The fact that the Moderna and Pfizer’s RNA vaccines have close to 90% efficacy, exceeding the effectiveness of more traditional vaccines, has provided us with hope for a future where COVID-19 is no longer deadly.&lt;/p&gt;&lt;p style="font-size: 80%;"&gt;That changes everything !&lt;/p&gt;&lt;p&gt;It takes less time to develop RNA therapeutics than traditional therapeutics because you skip two difficult and time consuming steps. These two steps are making protein based on the code, and manufacturing the protein.&lt;/p&gt;&lt;p&gt;RNA therapeutics goes directly from RNA code information to manufacturing of the RNA therapeutics in one quick step.&lt;/p&gt;&lt;p&gt;The hurdle has been that RNA isn’t stable, its designed to be a transient molecule in our biology. The second hurdle has been to get the RNA into the cells.&lt;/p&gt;&lt;p&gt;Both BioNtech/Pfizer and Moderna have overcome those two hurdles and are now in the late stages of a clinical study...&lt;a href=https://www.genomicexpression.com/blog/how-rna-changed-the-future-of-life-science&gt;Read More&lt;/a&gt;</description>
    </item>
  </channel>
</rss>
